Insider Trading30 Jun 2026, 04:07 pm
Natco Pharma Closes Trading Window for Insider Trading
AI Summary
Natco Pharma Ltd has announced the closure of its trading window for directors, designated persons, and connected individuals. This restriction will be in effect from July 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter ending June 30, 2026. The specific date for the board meeting to announce these results will be communicated later. This measure is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015, aimed at preventing potential misuse of unpublished price-sensitive information.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for directors, designated persons, and connected individuals.
- Restriction lasts until 48 hours post Q1 FY27 results declaration.
- Aims to comply with SEBI Insider Trading Regulations.
- Board meeting date for results to be announced later.
Price Impact
More from NATCOPHARM